Piramal Pharma

Indian conglomerate Piramal Enterprises Ltd (PEL) said on Thursday it was demerging its pharmaceutical business and listing it as a separate entity as part of a move to simplify its corporate structure.

Piramal Pharma Share Price: Piramal Enterprises shares rose to as high as Rs 1,387.55 apiece on the BSE during the session.

Piramal Pharma will use the capital raised through the dealto accelerate its organic and inorganic growth plans.

Pharma major Piramal Enterprises on Thursday said Saridon, its pain relief tablet, has been exempted from the list of banned fixed dose combinations (FDCs) by the Supreme Court.

North America and Europe account for over 70 per cent of the company's revenue from pharmaceuticals business.

HDFC Securities says the Nifty Pharma sub-index of NSE could bounce back up to 9600-9700 levels in next 2-3 months compared to its current value of 9,250.

Mr Piramal curtailed his presence in healthcare after he sold erstwhile Piramal Healthcare's domestic formulations division for $3.7 billion to Abbott in 2010.

Janssen will continue to sell the products on behalf of Piramal until the marketing authorisations or relevant business relations are transferred to Piramal.

Morepen Laboratories shares surged as much as 11per cent on Friday on a report that the Delhi-based pharma company is in talks to sell its OTC (over-the-counter) business.

The Competition Commission of India (CCI) has approved Ajay Piramal-led Piramal Enterprises' proposed acquisition of four brands from pharmaceutical major Pfizer.

Government is considering a proposal to relax foreign direct investment (FDI) norms in existing pharmaceutical companies with a view to attracting more overseas inflows.

Government on Monday sought vacation of Delhi High Court's interim order staying the ban on some fixed dose combinations (FDC) medicines, saying it would be "against public interest and patient safety" and alleging that the drug firms' sole objective was to make profits.

Piramal Enterprises Ltd is exploring buying nutritional supplements and cough and cold brands to grow its consumer healthcare business to among the three largest in the country by 2020, a senior executive said.

Piramal Pharma Solutions is an integrated solutions provider offering comprehensive range of services across the drug lifecycle. With a successful performance record of over four-decade in API supply (active pharmaceutical ingredients), drug products, drug discovery services, and with supply facilities in North America, Europe and Asia, it has esta...

For the year ended March 31, 2014, the company posted a net loss of Rs 501.41 crore as against that of Rs 227.29 crore in 2012-13.

Indian conglomerate Piramal Enterprises Ltd (PEL) said on Thursday it was demerging its pharmaceutical business and listing it as a separate entity as part of a move to simplify its corporate structure.

Piramal Pharma Share Price: Piramal Enterprises shares rose to as high as Rs 1,387.55 apiece on the BSE during the session.

Piramal Pharma will use the capital raised through the dealto accelerate its organic and inorganic growth plans.

Pharma major Piramal Enterprises on Thursday said Saridon, its pain relief tablet, has been exempted from the list of banned fixed dose combinations (FDCs) by the Supreme Court.

North America and Europe account for over 70 per cent of the company's revenue from pharmaceuticals business.

HDFC Securities says the Nifty Pharma sub-index of NSE could bounce back up to 9600-9700 levels in next 2-3 months compared to its current value of 9,250.

Mr Piramal curtailed his presence in healthcare after he sold erstwhile Piramal Healthcare's domestic formulations division for $3.7 billion to Abbott in 2010.

Janssen will continue to sell the products on behalf of Piramal until the marketing authorisations or relevant business relations are transferred to Piramal.

Morepen Laboratories shares surged as much as 11per cent on Friday on a report that the Delhi-based pharma company is in talks to sell its OTC (over-the-counter) business.

The Competition Commission of India (CCI) has approved Ajay Piramal-led Piramal Enterprises' proposed acquisition of four brands from pharmaceutical major Pfizer.

Government is considering a proposal to relax foreign direct investment (FDI) norms in existing pharmaceutical companies with a view to attracting more overseas inflows.

Government on Monday sought vacation of Delhi High Court's interim order staying the ban on some fixed dose combinations (FDC) medicines, saying it would be "against public interest and patient safety" and alleging that the drug firms' sole objective was to make profits.

Piramal Enterprises Ltd is exploring buying nutritional supplements and cough and cold brands to grow its consumer healthcare business to among the three largest in the country by 2020, a senior executive said.

Piramal Pharma Solutions is an integrated solutions provider offering comprehensive range of services across the drug lifecycle. With a successful performance record of over four-decade in API supply (active pharmaceutical ingredients), drug products, drug discovery services, and with supply facilities in North America, Europe and Asia, it has esta...

For the year ended March 31, 2014, the company posted a net loss of Rs 501.41 crore as against that of Rs 227.29 crore in 2012-13.